Viral vectors get the green light

WASHINGTON - The FDA's Vaccines and Related Biological Products Advisory Committee gave a green light to the continued use of viral vectors for delivery of gene therapies and approved the FDA's current methods of regulating related technologies.

Up to now, most gene